124 related articles for article (PubMed ID: 10376767)
1. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities.
Cravchik A; Gejman PV
Pharmacogenetics; 1999 Apr; 9(2):199-206. PubMed ID: 10376767
[TBL] [Abstract][Full Text] [Related]
2. Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid.
Feng J; Sobell JL; Heston LL; Cook EH; Goldman D; Sommer SS
Am J Med Genet; 1998 Mar; 81(2):172-8. PubMed ID: 9613858
[TBL] [Abstract][Full Text] [Related]
3. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
D'Aoust JP; Tiberi M
Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
[TBL] [Abstract][Full Text] [Related]
4. Activation of spinal d1/d5 receptors induces late-phase LTP of C-fiber-evoked field potentials in rat spinal dorsal horn.
Yang HW; Zhou LJ; Hu NW; Xin WJ; Liu XG
J Neurophysiol; 2005 Aug; 94(2):961-7. PubMed ID: 15829590
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence.
Demchyshyn LL; McConkey F; Niznik HB
J Biol Chem; 2000 Aug; 275(31):23446-55. PubMed ID: 10807903
[TBL] [Abstract][Full Text] [Related]
6. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors.
Liu F; Wan Q; Pristupa ZB; Yu XM; Wang YT; Niznik HB
Nature; 2000 Jan; 403(6767):274-80. PubMed ID: 10659839
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes.
Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD
Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, and functional analysis of human dopamine D1 receptors.
Sun WC; Jin L; Cao Y; Wang LZ; Meng F; Zhu XZ
Acta Pharmacol Sin; 2005 Jan; 26(1):27-32. PubMed ID: 15659110
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
Lan H; Durand CJ; Teeter MM; Neve KA
Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
[TBL] [Abstract][Full Text] [Related]
10. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
11. Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization.
Jiang D; Sibley DR
Mol Pharmacol; 1999 Oct; 56(4):675-83. PubMed ID: 10496949
[TBL] [Abstract][Full Text] [Related]
12. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
[TBL] [Abstract][Full Text] [Related]
13. Synergistic requirements for the induction of dopaminergic D1/D5-receptor-mediated LTP in hippocampal slices of rat CA1 in vitro.
Navakkode S; Sajikumar S; Frey JU
Neuropharmacology; 2007 Jun; 52(7):1547-54. PubMed ID: 17433377
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.
Wu WL; Burnett DA; Spring R; Greenlee WJ; Smith M; Favreau L; Fawzi A; Zhang H; Lachowicz JE
J Med Chem; 2005 Feb; 48(3):680-93. PubMed ID: 15689153
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced cell surface trafficking of an intracellularly sequestered D1 dopamine receptor homo-oligomer.
Kong MM; Fan T; Varghese G; O'dowd BF; George SR
Mol Pharmacol; 2006 Jul; 70(1):78-89. PubMed ID: 16597839
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
Zhang J; Chen X; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
[TBL] [Abstract][Full Text] [Related]
17. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
Saklayen SS; Mabrouk OS; Pehek EA
J Pharmacol Exp Ther; 2004 Oct; 311(1):342-8. PubMed ID: 15175419
[TBL] [Abstract][Full Text] [Related]
18. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
[TBL] [Abstract][Full Text] [Related]
19. Identification of human dopamine D1-like receptor agonist using a cell-based functional assay.
Jiang N; Ou-Yang KQ; Cai SX; Hu YH; Xu ZL
Acta Pharmacol Sin; 2005 Oct; 26(10):1181-6. PubMed ID: 16174433
[TBL] [Abstract][Full Text] [Related]
20. Differences between A 68930 and SKF 82958 could suggest synergistic roles of D1 and D5 receptors.
Nergårdh R; Oerther S; Fredholm BB
Pharmacol Biochem Behav; 2005 Nov; 82(3):495-505. PubMed ID: 16318870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
